Literature DB >> 21138793

Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients.

Susana Rocha1, Elísio Costa, Petronila Rocha-Pereira, Fátima Ferreira, Esmeralda Cleto, José Barbot, Alexandre Quintanilha, Luís Belo, Alice Santos-Silva.   

Abstract

Hereditary spherocytosis (HS) is usually classified as mild, moderate or severe using conventional features, namely, hemoglobin (Hb) concentration, reticulocyte count and bilirubin levels, which do not always contribute to an adequate clinical classification. The aim of our study was to establish the importance of some laboratory routine parameters, as markers of HS clinical outcome, by studying a control group (n=26) and unsplenectomized HS patients (n=82) presenting mild, moderate or severe HS. We performed a basic hematologic study and evaluated the reticulocyte count, bilirubin, erythropoietin (EPO) and soluble transferrin receptor (sTfR) levels; the osmotic fragility (OFT) and criohemolysis tests (CHT); the ratios Hb/MCHC (mean cell hemoglobin concentration), Hb/RDW (red cell distribution width) and MCHC/RDW, were calculated. Hb changed significantly in accordance with HS severity, but not reticulocytes or bilirubin. We found that MCHC, RDW, EPO, sTfR, OFT, CHT and the calculated ratios were significantly changed in patients, and, therefore, were valuable as complementary diagnostic tools for HS. Moreover, RDW, Hb/MCHC, Hb/RDW and MCHC/RDW changed significantly with worsening of HS; thus, they are also good markers for the clinical outcome of HS. In conclusion, we propose the use of these routine parameters as useful to complement the analysis of HS severity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138793     DOI: 10.1016/j.bcmd.2010.11.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  Back to the "Gold Standard": How Precise is Hematocrit Detection Today?

Authors:  Leonid Livshits; Tal Bilu; Sari Peretz; Anna Bogdanova; Max Gassmann; Harel Eitam; Ariel Koren; Carina Levin
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

2.  Cryohemolysis, erythrocyte osmotic fragility, and supplementary hematimetric indices in the diagnosis of hereditary spherocytosis.

Authors:  Ledesma Achem Miryam Emilse; Haro Cecilia; Terán Magdalena María; Mónaco María Eugenia; Issé Blanca Alicia; Sandra Stella Lazarte
Journal:  Blood Res       Date:  2018-03-27

3.  Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis.

Authors:  Rick Huisjes; Asya Makhro; Esther Llaudet-Planas; Laura Hertz; Polina Petkova-Kirova; Liesbeth P Verhagen; Silvia Pignatelli; Minke A E Rab; Raymond M Schiffelers; Elena Seiler; Wouter W van Solinge; Joan-LLuis Vives Corrons; Lars Kaestner; Maria Mañú-Pereira; Anna Bogdanova; Richard van Wijk
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Hereditary spherocytosis: Consequences of delayed diagnosis.

Authors:  Sarah C Steward; Allen R Chauvenet; Chibuzo O'Suoji
Journal:  SAGE Open Med       Date:  2014-08-16

5.  Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice.

Authors:  Ilya S Zhukov; Larisa G Kubarskaya; Inessa V Karpova; Anastasia N Vaganova; Marina N Karpenko; Raul R Gainetdinov
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.